Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Multifocal motor neuropathy

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might multifocal motor neuropathy be treated?

Treatment for multifocal motor neuropathy varies. Some individuals experience only mild, modest symptoms and require no treatment.[1] For others, treatment generally consists of intravenous immunoglobulin (IVIg) or immunosuppressive therapy with cyclophosphamide.[1] Improvement in muscle strength usually begins within 3 to 6 weeks after treatment is started. Most patients who receive treatment early experience little, if any, disability. However, there is evidence of slow progression over many years.[1]
Last updated: 5/1/2013

  1. NINDS Multifocal Motor Neuropathy Information Page. National Institute of Neurological Disorders and Stroke. Accessed 5/1/2013.

Clinical Trials & Research for this Disease

  • lists trials that are studying or have studied Multifocal motor neuropathy. Click on the link to go to to read descriptions of these studies.